Financhill
Back

State Street SPDR SSGA Multi-Asset Real Return ETF Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
42

RLY
State Street SPDR SSGA Multi-Asset Real Return ETF

Last Price:
$31.86
Seasonality Move:
-0.51%
Sell
43

CRSP
CRISPR Therapeutics AG

Last Price:
$55.85
Seasonality Move:
14.46%
Sell
42
State Street SPDR SSGA Multi-Asset Real Return ETF (RLY) is a Sell

Is State Street SPDR SSGA Multi-Asset Real Return ETF a Buy, Sell or Hold?

  • The current State Street SPDR SSGA Multi-Asset Real Return ETF [RLY] share price is $31.83. The Score for RLY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • RLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $55.86. The Score for CRSP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLY Stock Price Chart

What is State Street SPDR SSGA Multi-Asset Real Return ETF's stock price today?

  • The State Street SPDR SSGA Multi-Asset Real Return ETF share price today is $31.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RLY is experiencing slight selling pressure.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $55.86
    The current trend is relatively stagnant and CRSP is experiencing slight buying pressure.

RLY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.97 Buy
Relative Strength Index (14 RSI): 56.56 Buy
Chaikin Money Flow: -5908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (31.19 - 31.89) Buy
Bollinger Bands (100): (30.11 - 31.51) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 49.16 Sell
Chaikin Money Flow: 78181 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.94 - 57.06) Buy
Bollinger Bands (100): (52.44 - 65.4) Sell

RLY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.78 Buy
20-day SMA: 31.64 Buy
50-day SMA: 31.33 Buy
200-day SMA: 29.69 Buy
8-day EMA: 16.82 Buy
20-day EMA: 8.24 Buy
50-day EMA: 3.59 Buy
200-day EMA: 0.94 Buy

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.25 Sell
20-day SMA: 55.05 Buy
50-day SMA: 58.96 Sell
200-day SMA: 51.1 Buy
8-day EMA: 55.79 Buy
20-day EMA: 55.79 Buy
50-day EMA: 56.36 Sell
200-day EMA: 37.56 Buy

State Street SPDR SSGA Multi-Asset Real Return ETF Earnings Growth & RLY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.

State Street SPDR SSGA Multi-Asset Real Return ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):